Feedback / Questions
sabirnetug IV (ACU193 IV) - Acumen Pharma
sabirnetug SC (ACU193 SC) - Acumen Pharma
https://www.globenewswire.com/news-release/2024/05/08/2877741/0/en/Acumen-Pharmaceuticals-Announces-First-Patient-Dosed-in-ALTITUDE-AD-a-Phase-2-Clinical-Trial-of-Sabirnetug-ACU193-in-Early-Alzheimer-s-Disease.html
May 8, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next